AboutSkin Dermatology
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cohen, Joel
NCT03573401: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Active, not recruiting
3
186
US
Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT), ALA-PDT, Ameluz®-PDT, Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
Biofrontera Bioscience GmbH
Superficial Basal Cell Carcinoma
03/24
02/29
VOLIDO, NCT05386030: Saypha® VOLUME Lidocaine for Midface Augmentation

Completed
3
562
US
saypha® VOLUME Lidocaine, Juvéderm® Voluma™ XC
Croma-Pharma GmbH
Moderate to Severe Midface Volume Deficit
10/23
12/24
NCT05662202: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Active, not recruiting
3
172
US
BF-200 ALA and red light LED lamp, Vehicle and red light LED lamp
Biofrontera Bioscience GmbH
Actinic Keratoses
08/25
05/26
NCT05524805: BTL-785F Device for Non-invasive Treatment of Wrinkles and Improvement of the Face Appearance

Completed
N/A
23
US
BTL-785-7 Treatment
BTL Industries Ltd.
Wrinkle
05/23
04/24
Dahler, Deborah
ASCEND, NCT05295732: The Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis

Completed
3
209
Europe, Canada, US
TMB-001, Matching Vehicle
Timber Pharmaceuticals Inc., LEO Pharma
Ichthyosis
06/24
09/24
NCT05830968: Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne

Recruiting
N/A
42
US
Morpheus8 Applicator Radiofrequency device
InMode MD Ltd.
Inflammatory Acne Vulgaris
05/25
05/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cohen, Joel
NCT03573401: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Active, not recruiting
3
186
US
Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT), ALA-PDT, Ameluz®-PDT, Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
Biofrontera Bioscience GmbH
Superficial Basal Cell Carcinoma
03/24
02/29
VOLIDO, NCT05386030: Saypha® VOLUME Lidocaine for Midface Augmentation

Completed
3
562
US
saypha® VOLUME Lidocaine, Juvéderm® Voluma™ XC
Croma-Pharma GmbH
Moderate to Severe Midface Volume Deficit
10/23
12/24
NCT05662202: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Active, not recruiting
3
172
US
BF-200 ALA and red light LED lamp, Vehicle and red light LED lamp
Biofrontera Bioscience GmbH
Actinic Keratoses
08/25
05/26
NCT05524805: BTL-785F Device for Non-invasive Treatment of Wrinkles and Improvement of the Face Appearance

Completed
N/A
23
US
BTL-785-7 Treatment
BTL Industries Ltd.
Wrinkle
05/23
04/24
Dahler, Deborah
ASCEND, NCT05295732: The Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis

Completed
3
209
Europe, Canada, US
TMB-001, Matching Vehicle
Timber Pharmaceuticals Inc., LEO Pharma
Ichthyosis
06/24
09/24
NCT05830968: Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne

Recruiting
N/A
42
US
Morpheus8 Applicator Radiofrequency device
InMode MD Ltd.
Inflammatory Acne Vulgaris
05/25
05/26

Download Options